🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This three-pager is a must-read by every oncologist. Chris Booth is one of my heroes #timetoxicity “Thus, intensive treatments associated with more time toxicity are not incorrect choices themselves, and decisions for patients should be individualized. The most important first

📣 Call for Papers: Special Issue Gender-specific differences in radiation oncology treatment Lisa Deloch link.springer.com/journal/66/upd…

Incredible work by Sunnybrook Health Sciences Centre CNS spine #SBRT team working on data driven imaging frequency practices post spine SBRT. We need to implement it and study it further. 👏 pubmed.ncbi.nlm.nih.gov/38373656/

Estimating the risk of brain metastasis for patients newly diagnosed with cancer Our team built highly predictive models to help physicians and National Comprehensive Cancer Network (NCCN) guidelines in recommending brain MRI pubmed.ncbi.nlm.nih.gov/38388667/ rdcu.be/dzlqQ Webtool: tinyurl.com/brain-mets

NEW The TROG 15.03 FASTRACK II non-randomised phase 2 trial investigated the efficacy of stereotactic ablative body radiotherapy for primary renal cell cancer. #rccsm #radonc thelancet.com/journals/lanon…

I would like to thank SNO and our sponsor Varian for supporting this supplement. I had the honor to be editor of Pushing the Boundaries of Radiation Technology for the Management of CNS tumours. Enjoy academic.oup.com/neuro-oncology…

🙋‍♀️Heute ehren wir die Beiträge & Erfolge von Frauen & Mädchen- insbesondere in der Radioonkologie. An alle Wissenschaftlerinnen und die, die es werden möchten: Eure Neugier kann die Welt verändern! Die DEGRO unterstützt & ermutigt euch auf eurem Weg. #RadOnc #InspireInclusion

1/n Our phase II trial publication is finally out describing a simple strategy of boosting the primary tumor in locally-advanced #lungcancer with 6-8 Gy x 2 shortly prior to conventional chemoradiation (CRT)❗️ #lcsm #SBRT #SABR #NSCLC #radonc City of Hope City of Hope - Department of Radiation Oncology City of Hope Department of Medical Oncology

1/ Thank you 🙏🏾, patients, families, and investigators, for contributing to the SEISMIC 🫁trial out now The Lancet Respiratory Medicine - shorturl.at/qxMUY. Led by 🫁Daniel Steinfort, this international multicentre recruited n=155 trial from 🇦🇺, 🇨🇦, 🇺🇸, 🇳🇱 #radonc CTSurgSocMedNetwork Peter Mac Radiation Oncology

Just out! 🗞️Hoegen-Sassmannshausen et al. on carbon ion radiotherapy of hepatocellular carcinoma providing excellent local control in the prospective phase 1 PROMETHEUS trial! Universitätsklinikum Heidelberg Radiation Oncology @Heidelberg University Hosp. JHEP Reports sciencedirect.com/science/articl…

📢 Das #Leitlinienprogramm Onkologie der #AWMF hat erstmals die S3-Leitlinie zur Diagnostik, Therapie, Prävention u. Nachsorge des Oro- und Hypopharynxkarzinoms veröffentlicht! Die #DEGRO, #ARO & BVDST waren beteiligt. 👉Zur Leitlinie: bit.ly/3vnP9sj

Dr Narek Shaverdian presents at our "Work in Progress" Thoracic #radonc meeting Memorial Sloan Kettering Cancer Center on why rates of #radiationpneumonitis are ⬆️over time with raising use of immunotherapy & why it is an import target for intervention to improve #lungCancer outcomes. #lcsm ☢️🫁⚡️

🚨Our NEW paper out from POP-RT trial Vedang Murthy in IJROBP - The Red Journal !!!🤩 Elective pelvic #radiotherapy in HR-VHR #prostatecancer ⬆️ ⬆️BFFS, DFS, MFS Does toxicity REALLY increase⁉️ Short: NO Long: ~10% higher gr2 late urinary (p=NS) 1/ doi.org/10.1016/j.ijro…

No SUNSET on this ultracentral trial of 60 Gy in 8 fractions <7% grade 3-5 AEs, ~90% local control Online at: redjournal.org/article/S0360-… Meredith Giuliani Benjamin Lok, MD Alex Louie MD, PhD Houda Bahig, MD PhD Andrea Bezjak Scott Bratman Dr. David Palma

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial out in European Urology sciencedirect.com/science/articl… The PACE-A trial is a phase 3⃣ randomized study comparing patient-reported outcomes between

Major congrats to my friend Dr Sofia Rivera on the HypoG-01 just presented at #ESMO2024 Hypofractionation not inferior to conventional fractionation for #BreastCancer with nodal RT. ✅Similar toxicity ✅Similar efficacy (BCSM OS LRFS DMFS) 3 weeks is the way to go!

Thoughtful discussion by Dr Charlotte Coles. #ESMO2024

Delighted to share the results of #PACE B trial, published in NEJM today 5 fraction SBRT is non inferior to CRT! nejm.org/media/doi/full… Alison Tree 💙 ICR-CTSU Prof Emma Hall The Royal Marsden NHS Foundation Trust Dr. Andrew Loblaw Clive Peedell Dr Shaun Tolan Prof Joe O'Sullivan Prof Suneil Jain

Thanks to all the patients that agreed to be randomised, and to the brilliant team #PACE that made it possible! Prof Emma Hall Alison Tree 💙 Dr. Andrew Loblaw The Royal Marsden NHS Foundation Trust

Reminder - Virtual Grand Rounds in Radiation Oncology This Wednesday 17:00 CET PACE-A and PACE-B studies discussed by Prof. N. van As 👇